Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction and left ventricular dysfunction: A 24- month follow up study

Bratislava Medical Journal

Volumn 113, Issue 4, 2012, Pages 220-227

  Skalicka, H ^a   Horak, J ^a   Kobylka, P ^b   Palecek, T ^a   Linhart, A ^a   Aschermann, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Bone marrow derived mononuclear cells; Left ventricular ejection fraction; Myocardial infarction; Remodeling

Indexed keywords

ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; INJECTION; MALE; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TRANSPLANTATION, AUTOLOGOUS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84871795215     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2012_051     Document Type: Article

References (50)

1. Bolognese L, Neskovic AN, Parodi G et al. Left Ventricular Remodeling After Primary Coronary Angioplasty: Patterns of Left Ventricular Dilation and Long-Term Prognostic Implications. Circulation 2002; 106 (18): 2351-2357.
2. Pfeffer MA, McMurray JJ, Velazquez EJ et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349 (20): 1893-1906.
3. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410 (6829): 701-705.
4. Kawamoto A, Gwon HC, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103 (5): 634-637.
5. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7 (4): 430-436.
6. Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106 (15): 1913-1918.
7. Assmus B, Schachinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106 (24): 3009-3017.
8. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bonemarrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364 (9429): 141-148.
9. Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367 (9505): 113-121.
10. Schachinger V, Erbs S, Elsasser A et al. Intracoronary bone marrowderived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355 (12): 1210-1221.
11. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J 2005; 39 (3): 150-158.
12. Ge J, Li Y, Qian J et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCTSTAMI). Heart 2006; 92 (12): 1764-1767.
13. Caplice NM. The future of cell therapy for acute myocardial infarction. Nat Clin Pract Cardiovasc Med 2006; 3 Suppl 1: S129-132.
14. Abdel-Latif A, Bolli R, Tleyjeh IM et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167 (10): 989-997.
15. Halkin A, Singh M, Nikolsky E et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005; 45 (9): 1397-1405.
16. Penicka M, Horak J, Kobylka P et al. Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study. J Am Coll Cardiol 2007; 49 (24): 2373-2374.
17. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2 (5): 358-367.
18. Araszkiewicz A, Lesiak M, Grajek S, Prech M, Cieslinski A. Relationship between tissue reperfusion and postinfarction left ventricular remodelling in patients with anterior wall myocardial infarction treated with primary coronary angioplasty. Kardiol Pol 2006; 64 (4): 383-388; discussion 389-390.
19. Orlic D. Stem cell repair in ischemic heart disease: an experimental model. Int J Hematol 2002; 76 Suppl 1: 144-145.
20. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114 (6): 763-776.
21. Tomita S, Mickle DA, Weisel RD et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002; 123 (6): 1132-1140.
22. Moelker AD, Baks T, van den Bos EJ et al. Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction. Eur Heart J 2006; 27 (24): 3057-3064.
23. Badorff C, Brandes RP, Popp R et al. Transdifferentiation of bloodderived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003; 107 (7): 1024-1032.
24. Tse HF, Yiu KH, Lau CP. Bone marrow stem cell therapy for myocardial angiogenesis. Curr Vasc Pharmacol 2007; 5 (2): 103-112.
25. Aviles FF, San Roman JA, Garcia Frade J et al. [Intracoronary stem cell transplantation in acute myocardial infarction]. Rev Esp Cardiol 2004; 57 (3): 201-208.
26. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361 (9351): 45-46.
27. Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004; 363 (9411): 751-756.
28. Meluzin J, Mayer J, Groch L et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006; 152 (5): 975 e9-15.
29. Janssens S, Theunissen K, Boogaerts M, Van de Werf F. Bone marrow cell transfer in acute myocardial infarction. Nat Clin Pract Cardiovasc Med 2006; 3 Suppl 1: S69-72.
30. Hirsch A, Nijveldt R, van der Vleuten PA et al. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial. Catheter Cardiovasc Interv 2008; 71 (3): 273-281.
31. Charwat S, Gyongyosi M, Lang I et al. Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol 2008; 36 (6): 672-680.
32. Janssens S. Stem cell therapy in acute myocardial infarction. Acta Clin Belg 2007; 62 (5): 342-734.
33. Schachinger V, Erbs S, Elsasser A et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006; 27 (23): 2775-2783.
34. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008; 29 (15): 1807-1818.
35. Lipinski MJ, Biondi-Zoccai GG, Abbate A et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007; 50 (18): 1761-1767.
36. Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance STelevation infarct regeneration) trial. Circulation 2006; 113 (10): 1287-1294.
37. Yousef M, Schannwell CM, Kostering M, Zeus T, Brehm M, Strauer BE. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 2009; 53 (24): 2262-2269.
38. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81 (4): 1161-1172.
39. Sutton MSJ, Pfeffer MA, Moye L et al. Cardiovascular Death and Left Ventricular Remodeling Two Years After Myocardial Infarction: Baseline Predictors and Impact of Long-term Use of Captopril: Information From the Survival and Ventricular Enlargement (SAVE) Trial. Circulation 1997; 96 (10): 3294-3299.
40. Sheiban I, Fragasso G, Rosano GM et al. Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 2001; 38 (2): 464-471.
41. Giannuzzi P, Temporelli PL, Bosimini E et al. Heterogeneity of left ventricular remodeling after acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico- 3 Echo Substudy. Am Heart J 2001; 141 (1): 131-138.
42. Sutton MGSJ, Sharpe N. Left Ventricular Remodeling After Myocardial Infarction Pathophysiology and Therapy. Circulation 2000; 101 (25): 2981-2988.
43. Solomon SD, Glynn RJ, Greaves S et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med 2001; 134 (6): 451-458.
44. Hole T, Vegsundvag JA, Morstol TH, Skaerpe T. Early changes in left ventricular volume and function are predictors for long-term remodeling in patients with acute transmural myocardial infarction and preserved systolic function. J Am Soc Echocardiogr 2003; 16 (6): 630-637.
45. Penicka M, Widimsky P, Kobylka P, Kozak T, Lang O. Images in cardiovascular medicine. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation 2005; 112 (4): e63-65.
46. Yeh ET, Zhang S, Wu HD, Korbling M, Willerson JT, Estrov Z. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003; 108 (17): 2070-2073.
47. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428 (6983): 668-673.
48. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428 (6983): 664-668.
49. Korf-Klingebiel M, Kempf T, Sauer T et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008; 29 (23): 2851-2858.
50. Boyle AJ, Whitbourn R, Schlicht S et al. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol 2006; 109 (1): 21-27.